Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Politics

Jay Bhattacharya, prominent physician and economist, nominated by Trump for NIH director

by admin November 27, 2024
November 27, 2024
Jay Bhattacharya, prominent physician and economist, nominated by Trump for NIH director

Stanford-trained physician and economist Jay Bhattacharya has officially been nominated by President-elect Donald Trump to serve as the next director of the National Institutes of Health (NIH).

Trump made the announcement in a Truth Social post, writing: ‘I am thrilled to nominate Jay Bhattacharya, MD, PhD, to serve as Director of the National Institutes of Health. Dr. Bhattacharya will work in cooperation with Robert F. Kennedy Jr. to direct the Nation’s Medical Research, and to make important discoveries that will improve Health, and save lives.’

Bhattacharya met this week with Robert F. Kennedy Jr., who was nominated by Trump to lead the Department of Health and Human Services, which oversees the NIH and other health agencies, and impressed the former presidential candidate with his ideas to overhaul the NIH, which oversees U.S. biomedical research, according to a report by The Washington Post.

The NIH also awards funding grants to hundreds of thousands of researchers, oversees clinical trials on its Maryland campus and supports a variety of efforts to develop drugs and therapeutics.

The nominee for the NIH director must be confirmed by the Senate, which will have a Republican majority beginning in January.

Bhattacharya has called for moving the NIH’s focus toward funding more innovative research and cutting the influence of some of its longest-serving officials.

Kennedy Jr. has played a central role in choosing top health care staff and deputies for Trump’s next administration, including Johns Hopkins surgeon Marty Makary, who Trump selected to lead the Food and Drug Administration, and internal medicine physician and former Republican congressman from Florida Dave Weldon, who Trump chose to head the Centers for Disease Control and Prevention, according to the report.

Bhattacharya and Makary worked together on a blueprint for a proposed commission to investigate the nation’s coronavirus response, the report noted.

Trump’s selections of Makary, Weldon and family and emergency medicine physician Janette Nesheiwat, who the president-elect nominated to serve as surgeon general, also must be confirmed by the Senate.

Bhattacharya was a prominent critic of the federal government’s COVID-19 response during the early days of the pandemic. He co-wrote an open letter in October 2020, during Trump’s first term, that called for the government to roll back pandemic shutdowns but maintain ‘focused protections’ for vulnerable populations, such as the elderly.

The suggestion was supported by Republican lawmakers and many Americans who were critical of shutdowns and wanted to return to pre-pandemic life. However, public health experts, including then-NIH Director Francis S. Collins, criticized the proposal as premature and dangerous amid the spread of COVID-19 at a time when vaccines were not yet available.

Bhattacharya has also called for rolling back the power of some of the 27 institutes and centers that make up the NIH, arguing that some career civil servants wrongly shaped national policies at the height of the pandemic and did not allow dissenting perspectives.

He, along with other critics of the agency, have criticized former Director of the National Institute of Allergy and Infectious Diseases Anthony Fauci, who helped shape the nation’s coronavirus response during the Trump and Biden administrations before leaving the federal government in December 2022.

The NIH has also been investigated by congressional lawmakers over the pandemic response, with Republicans charging that the agency’s leaders mismanaged the response to the virus and calling for the agency to be overhauled.

Current and former NIH officials, including Fauci, have defended the agency’s response, arguing that federal leaders generally did the best that they could to address the virus.

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Legal challenges on administrative reach expected in Trump’s deregulatory scheme, experts say
next post
Biden announces cease-fire plan between Israel and Hezbollah ending 14 months of fighting

Related Posts

Trump official blasts Washington Post for ‘fake news’...

February 28, 2025

Lloyd Austin warns against isolationism and insists Ukraine...

October 23, 2024

Russia is supplying Houthis with satellite data to...

October 26, 2024

Trump will attend Pope Francis’ funeral in Rome...

April 22, 2025

Trump picks Billy Long to head IRS, Kelly...

December 5, 2024

Trump’s authority to fire officials questioned in court...

March 8, 2025

Conservatives worry Congress won’t have ‘spine’ for spending...

December 7, 2024

Trump and his allies turn up the volume...

July 10, 2024

Freedom Caucus lawmaker Ralph Norman vows to ‘shake...

July 28, 2025

Biding Time: Trump assassination attempt overshadows calls for...

July 18, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Trump nominees squeezed between ‘blue slips’ and blue obstruction

      September 1, 2025
    • Trump says he will require voter ID with executive order

      September 1, 2025
    • Former FBI Director Robert Mueller has Parkinson’s disease: report

      September 1, 2025
    • Commencement of Henbury Field Program

      September 1, 2025
    • RCM to Acquire Webbs Consol Silver Project from Lode Res.

      September 1, 2025

    Categories

    • Business (1,092)
    • Investing (2,946)
    • Politics (3,598)
    • Stocks (1,155)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved